-+ 0.00%
-+ 0.00%
-+ 0.00%

Lexicon Pharmaceuticals Advances Pilavapadin to Phase 3 Trials for Diabetic Peripheral Neuropathic Pain Following Positive Phase 2 Data

Reuters·10/14/2025 12:01:22

Please log in to view news